Showing results (1131-1140 of 5,501) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|July 8, 2020
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's DiseaseWalter Reinisch, Krisztina Gecse, Jonas Halfvarson, et al.
Inflammatory Bowel Diseases|January 24, 2014
Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel diseaseK T Park, Wallace V Crandall, Jacqueline Fridge, et al.
Inflammatory Bowel Diseases|May 17, 2014
Mechanisms that mediate the development of fibrosis in patients with Crohn's diseaseChao Li, John F Kuemmerle
Inflammatory Bowel Diseases|May 17, 2014
The complement system in inflammatory bowel diseaseUmang Jain, Anthony R Otley, Johan Van Limbergen, et al.
Inflammatory Bowel Diseases|May 22, 2014
Endogenous regulation of inflammatory pain by T-cell-derived opioids: when friend turns to foeLilian Basso, Jérôme Boué, Arnaud Bourreille, et al.
Inflammatory Bowel Diseases|January 14, 2014
Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's diseaseAdriane R Neves, Morgana T L Castelo-Branco, Vanessa R Figliuolo, et al.
Inflammatory Bowel Diseases|January 14, 2014
Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from KoreaSang Hyoung Park, Suk-Kyun Yang, Soo-Kyung Park, et al.
Inflammatory Bowel Diseases|June 20, 2020
Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation GenesJudith R Kelsen, Noor Dawany, Maire A Conrad, et al.
Inflammatory Bowel Diseases|May 15, 2020
Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid InsuranceEdward L Barnes, Christina M Bauer, Robert S Sandler, et al.
Inflammatory Bowel Diseases|August 5, 2022
Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019Jeff Y Yang, Jennifer L Lund, Virginia Pate, et al.
Pageof 551